Department of Health Sciences, Campus de Las Lagunillas SN, University of Jaén, E-23071 Jaén, Spain.
Centre for Biomedical Research (CIBM), Biopathology and Regenerative Medicine Institute (IBIMER), University of Granada, E-18011 Granada, Spain.
Int J Mol Sci. 2022 Aug 21;23(16):9465. doi: 10.3390/ijms23169465.
Osteoporosis has been defined as the silent disease of the 21st century, becoming a public health risk due to its severity, chronicity and progression and affecting mainly postmenopausal women and older adults. Osteoporosis is characterized by an imbalance between bone resorption and bone production. It is diagnosed through different methods such as bone densitometry and dual X-rays. The treatment of this pathology focuses on different aspects. On the one hand, pharmacological treatments are characterized by the use of anti-resorptive drugs, as well as emerging regenerative medicine treatments such as cell therapies and the use of bioactive hydrogels. On the other hand, non-pharmacological treatments are associated with lifestyle habits that should be incorporated, such as physical activity, diet and the cessation of harmful habits such as a high consumption of alcohol or smoking. This review seeks to provide an overview of the theoretical basis in relation to bone biology, the existing methods for diagnosis and the treatments of osteoporosis, including the development of new strategies.
骨质疏松症已被定义为 21 世纪的无声疾病,由于其严重性、慢性和进展性,成为公共健康风险,主要影响绝经后妇女和老年人。骨质疏松症的特征是骨吸收和骨生成之间的失衡。它通过骨密度测定和双 X 射线等不同方法进行诊断。该病理学的治疗侧重于不同的方面。一方面,药物治疗的特点是使用抗吸收药物,以及新兴的再生医学治疗方法,如细胞疗法和使用生物活性水凝胶。另一方面,非药物治疗与应纳入的生活习惯有关,如体育活动、饮食以及戒除高酒精或吸烟等有害习惯。本综述旨在提供与骨生物学、现有诊断方法和骨质疏松症治疗相关的理论基础概述,包括新策略的发展。